These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6145111

  • 1. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [Abstract] [Full Text] [Related]

  • 2. The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine.
    Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1985 Mar; 24(3):193-7. PubMed ID: 3990920
    [Abstract] [Full Text] [Related]

  • 3. Behavioural consequences of the infusion of dopamine into the nucleus accumbens of the common marmoset (Callithrix jacchus).
    Barnes NJ, Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1987 Sep; 26(9):1327-35. PubMed ID: 2890118
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B, Domeney AM, Naylor RJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [Abstract] [Full Text] [Related]

  • 5. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B, Domeney AM, Naylor RJ.
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [Abstract] [Full Text] [Related]

  • 6. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.
    Costall B, Domeney AM, Naylor RJ.
    Psychopharmacology (Berl); 1984 Nov; 82(3):174-80. PubMed ID: 6144126
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B, Domeney AM, Naylor RJ, Tyers MB.
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B, Eniojukan JF, Naylor RJ.
    Eur J Pharmacol; 1983 Dec 23; 96(3-4):201-10. PubMed ID: 6426976
    [Abstract] [Full Text] [Related]

  • 15. Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens.
    Morgenstern R, Mende T, Gold R, Lemme P, Oelssner W.
    Pharmacol Biochem Behav; 1984 Oct 23; 21(4):501-6. PubMed ID: 6504948
    [Abstract] [Full Text] [Related]

  • 16. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM, Elands J, Király I, Wolterink G.
    Eur J Pharmacol; 1989 Aug 03; 166(3):441-52. PubMed ID: 2572429
    [Abstract] [Full Text] [Related]

  • 17. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
    Morgenstern R, Fink H.
    J Neural Transm; 1985 Aug 03; 61(3-4):151-60. PubMed ID: 3989521
    [Abstract] [Full Text] [Related]

  • 18. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R, Guerin JJ, Davis KL.
    Psychopharmacology (Berl); 1989 Aug 03; 98(3):386-91. PubMed ID: 2568659
    [Abstract] [Full Text] [Related]

  • 19. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 20. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM, Barnes NM, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Apr 01; 29(4):327-36. PubMed ID: 1971430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.